ESSEX INVESTMENT MANAGEMENT CO LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 201772
BOSTON, MA
Position in XERS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,667,615
+$1,330,555 QoQ
Shares Held
715,608
-4.3% QoQ
Ownership
0.393%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#33
of 238 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ESSEX INVESTMENT MANAGEMENT CO LLC holds $27,866,340 across 5 Drug Manufacturers - Specialty & Generic names. XERS ranks #3 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
241,382 | $15,436,378 | |
| 2 | LQDA |
Liquidia Corp
|
74,743 | $5,959,259 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
715,608 | $5,667,615 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
20,131 | $728,742 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
4,295 | $74,346 |
All Filings in XERS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,667,615 | 715,608 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,337,060 | 747,769 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,766,076 | 734,532 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,105,276 | 750,034 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,389,364 | 725,774 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,010,137 | 730,444 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,610,097 | 474,955 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||